Clinical Trials
371
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (258 trials with phase data)• Click on a phase to view related trials
Organ Dysfunction Changes in Acute Necrotizing Pancreatitis Patients With Sepsis Following Open Necrosectomy
- Conditions
- Necrotizing Pancreatitis
- First Posted Date
- 2025-10-01
- Last Posted Date
- 2025-10-01
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 700
- Registration Number
- NCT07201246
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, China, China
Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinoma
- Conditions
- Esophageal Squamour Cell Cancer
- Interventions
- First Posted Date
- 2025-09-25
- Last Posted Date
- 2025-09-25
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 41
- Registration Number
- NCT07191977
Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma
- Conditions
- Gastroesophageal Junction AdenocarcinomaHypofractionated Radiotherapy
- Interventions
- First Posted Date
- 2025-09-19
- Last Posted Date
- 2025-09-24
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 84
- Registration Number
- NCT07182565
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure
- Conditions
- Refractory Pancreatic Ductal AdenocarcinomaRefractory Pancreatic Adenocarcinoma
- Interventions
- First Posted Date
- 2025-09-16
- Last Posted Date
- 2025-09-16
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT07175389
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Retrospective Analysis of Quality of Life Changes in Patients Undergoing Parathyroidectomy for End-Stage Renal Disease
- Conditions
- Secondary Hyperparathyroidism Due to Renal CausesEnd Stage Renal Failure
- First Posted Date
- 2025-09-03
- Last Posted Date
- 2025-09-03
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT07151664
- Prev
- 1
- 2
- 3
- 4
- 5
- 74
- Next
News
Fat-Trapping Microbeads Show Promise for Drug-Free Weight Loss in Preclinical Study
Researchers at Sichuan University developed edible microbeads composed of green tea polyphenols, vitamin E, and alginate that trap dietary fats in the gastrointestinal tract to prevent absorption.
Neoadjuvant Immunochemotherapy Shows Promising Results in Locally Advanced Oral Squamous Cell Carcinoma
Neoadjuvant immunochemotherapy with camrelizumab plus nab-paclitaxel and cisplatin demonstrated a favorable pathological response in patients with locally advanced oral squamous cell carcinoma, achieving a 69% major pathological response rate and 41.4% pathological complete response rate.
ICG-HSA Complex Enhances Fluorescence Imaging in Laparoscopic Liver Resection: A Randomized Controlled Trial
A prospective, double-blind, randomized controlled trial is underway to evaluate a novel indocyanine green–human serum albumin (ICG-HSA) complex for fluorescence-guided laparoscopic anatomical liver resection (LALR).
Secukinumab and Adalimumab Show Distinct Benefits in Psoriatic Arthritis Treatment
A recent study comparing secukinumab and adalimumab for psoriatic arthritis (PsA) found both effective, but with distinct advantages.